High-level, β-catenin/TCF-dependent transgene expression in secondary colorectal cancer tissue

Molecular Therapy

Volumn 4, Issue 4, 2001, Pages 365-371

  Lipinski, Kai S ^a   Djeha, A Hakim ^a   Ismail, Tariq ^b   Mountain, Andrew ^a   Young, Lawrence S ^b   Wrighton, Christopher J ^a  

^a KEELE UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Adenovirus; CB1954; Colon cancer; Gene therapy; Nitroreductase; TCF 4; catenin

Indexed keywords

5 (1 AZIRIDINYL) 2,4 DINITROBENZAMIDE; BACTERIAL ENZYME; BETA CATENIN; BETA GALACTOSIDASE; NITROREDUCTASE; PRODRUG; VIRUS VECTOR;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER TISSUE; COLORECTAL CANCER; CONTROLLED STUDY; DEREGULATION; ESCHERICHIA COLI; GENE EXPRESSION; GENE TARGETING; GENE THERAPY; GENETIC CODE; HUMAN; HUMAN CELL; IN VIVO STUDY; LIVER; MALE; METASTASIS; MOUSE; NONHUMAN; PROMOTER REGION; T LYMPHOCYTE; TRANSGENE; TUMOR BIOPSY; TUMOR XENOGRAFT;

ADENOVIRIDAE; ANIMALIA; BACTERIA (MICROORGANISMS); ESCHERICHIA COLI;

EID: 0034755297     PISSN: 15250016     EISSN: None     Source Type: Journal    
DOI: 10.1006/mthe.2001.0468     Document Type: Article

References (25)

1. Gene-directed enzyme prodrug therapy
2. Suicide genes: Past, present and future perspectives
3. Combined adenovirus-mediated nitroreductase gene delivery and CB1954 treatment: A well-tolerated therapy for established solid tumors
4. Characterization of the cyclooxygenase-2 promoter in an adenoviral vector and its application for the mitigation of toxicity in suicide gene therapy of gastrointestinal cancers
5. Cloning of the complete gene for carcinoembryonic antigen: Analysis of its promoter indicates a region conveying cell type-specific expression
6. Transcriptional regulation of the carcinoembryonic antigen gene. Identification of regulatory elements and multiple nuclear factors
7. Wnt signaling and cancer
8. Linking colorectal cancer to Wnt signaling
9. Tumor cell-specific transgene expression prevents liver toxicity of the adeno-HSVtk/GCV approach
10. Nuclear translocation of β-catenin in colorectal cancer
11. Constitutive transcriptional activation by a β-catenin-Tcf complex in APC-/-colon carcinoma
12. Regulation of intracellular β-catenin levels by the adenomatous polyposis coli (APC) tumor-suppressor protein
13. Expression of E-cadherin-associated molecules (α-, β-, and γ-catenins and p120) in colorectal polyps
14. Cellular promoters incorporated into the adenovirus genome: Effects of viral regulatory elements on transcription rates and cell specificity of albumin and β-globin promoters
15. Targeting cell-specific gene expression with an adenovirus vector containing the lacZ gene under the control of the CFTR promoter
16. Suicide gene expression induced in tumour cells transduced with recombinant adenoviral, retroviral and plasmid vectors containing the ERBB2 promoter
17. Insulation from viral transcriptional regulatory elements improves inducible transgene expression from adenovirus vectors in vitro and in vivo
18. Modulation of the specificity and activity of a cellular promoter in an adenoviral vector
19. Somatic mutations of the β-catenin gene are frequent in mouse and human hepatocellular carcinomas
20. β-catenin, a novel prognostic marker for breast cancer: Its roles in cyclin D1 expression and cancer progression
21. Involvement of adenomatous polyposis coli (APC)/β-catenin signalling in human breast cancer
22. Stabilization of β-catenin by genetic defects in melanoma cell lines
23. AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by transfer of AXIN1
24. Expression of Escherichia coli B nitroreductase in established human tumor xenografts in mice results in potent antitumoral and bystander effects upon systemic administration of the prodrug CB1954
25. Tumour-specific therapeutic adenovirus vectors: Repression of transgene expression in healthy cells by endogenous p53